Expectation shapes experience. Tell a patient they are getting a powerful painkiller and they may feel relief even if the pill is sugar. That is the placebo effect, and it is strong enough to confound any trial that does not account for it. A blind study hides information from participants to keep their expectations from skewing the results.

In a single-blind study, participants do not know whether they are receiving the treatment or a control. The researchers do know, which creates a different problem: their expectations can influence how they measure outcomes, how they interact with participants, and how they interpret ambiguous results. That is why the double-blind design, where neither participants nor researchers know who gets what, is the standard for clinical trials. A third variation, the triple-blind study, also keeps the analysts who crunch the numbers in the dark until the code is broken.

Why blinding matters:

• Placebo effect. Belief in treatment can produce real symptom relief.
• Observer bias. Researchers may unconsciously favor the treatment arm.
• Reporting bias. Participants may overreport benefits or underreport side effects.
• Analysis bias. Statisticians may make different choices if they know group assignments.

Blinding is not always possible. Surgical trials, for example, are hard to fake. When blinding fails, researchers use other methods to reduce bias.